[Regulatory T lymphocytes CD4(+): current issues]

Aurélie Siri1, Hubert de Boysson, Guilaine Boursier

  • 1Master Immunotechnologies et biothérapies, université Pierre et Marie Curie, Paris, France. aurelie.siri@hotmail.fr

Medecine Sciences : M/S
|July 19, 2012
PubMed